Skip to main content
Equibles

GSA CAPITAL PARTNERS LLP

Position in HUMA — Humacyte, Inc.

CIK 1362033 LONDON, X0
Back to HUMA Full portfolio

Position in HUMA

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$784,453
+$632,791 QoQ
Shares Held
1,005,709
+302.5% QoQ
Ownership
0.362%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#17
of 163 holders
Holding Since
Jun 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HUMA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. HUMA ranks #47 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IOVA
Iovance Biotherapeutics, Inc.
 655,318 $2,726,122
2 IMVT
Immunovant, Inc.
 65,267 $2,514,737
3 GOSS
Gossamer Bio, Inc.
 14,986,947 $2,472,846
4 AXSM
Axsome Therapeutics, Inc.
 9,419 $2,305,488
5 CABA
Cabaletta Bio, Inc.
 668,563 $2,079,230
6 MLTX
MoonLake Immunotherapeutics
 106,695 $2,077,351
7 ATYR
aTYR PHARMA INC
 3,454,863 $2,062,553
8 CORT
Corcept Therapeutics Inc
 23,257 $2,022,196

All Filings in HUMA

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $784,453 1,005,709
2026-03-31 $151,662 249,856
2025-06-30 $1,345,424 643,744
2025-03-31 $471,785 276,707
2024-12-31 $744,556 147,437
2024-09-30 $654,529 120,318
2024-06-30 $1,076,059 224,179
2024-03-31 $619,042 199,049
2023-12-31 $1,241,310 437,081
2023-09-30 $1,042,839 355,918
2023-06-30 $424,953 148,585